Meet our Team
Oryzon’s management team is composed of passionate biopharma executives exploring new fields of epigenetic science to transform it into innovative personalized medicines for patients.
Management
-
Carlos Buesa
Chief Executive Officer (CEO) -
Jordi Xaus
Chief Scientific Officer (CSO) -
Michael Ropacki
Chief Medical Officer for CNS -
Sonia Gutierrez
Chief of Clinical Operations -
Enric Rello
Chief Operating Officer (COO), Chief Financial Officer (CFO) -
Neus Virgili
Chief Intellectual Property Officer (CIPO) -
Emili Torrell
Chief Business Development Officer (CBDO)
Strategic Advisor
Board Members
-
Carlos Buesa
President (Executive Director) -
Manuel López-Figueroa
Board Member (Independent Director) -
Luis Sánchez Quintana
Board Member (Independent Director) -
Konstantinos Alataris
Board Member (Independent Director) -
Montserrat Vendrell
Board Member (Independent Director) -
Pierre Beaurang
Board Member (Independent Director)
Clinical Advisory Board – CNS
Clinical Advisory Board – Oncology